Evaluation and Treatment of Patients With Lung Disease Not Participating in Research

NCT00001621 | Completed

• 2 other identifiers: 97006197-H-0061
• Study Type: observational
• Target: 280
• Locations: 1 country
• Sites: 1

Brief Summary

This study was developed in order for the professional-staff at the Pulmonary-Critical Care Medical Branch (PCCMB) of the National Heart, Lung, and Blood Institute to maintain their skills and increase their understanding of lung diseases. The study will permit PCCMB staff members to evaluate and treat patients with lung disease who do not meet the criteria for other research studies.

Conditions

Pulmonary Disease

Keywords

Teaching; Pulmonary Disease; Routine Testing; Medically Indicated; Pulmonary Function Test

Outcome Measures

Primary Outcomes (1)

• to permit PB staff to evaluate and treat patients with pulmonary disease who do not meet the criteria for existing research protocols.

  The purpose of this protocol is to permit PB staff to evaluate and treat patients with pulmonary disease who do not meet the criteria for existing research protocols.

  1 visit

Study Arms (1)

1

Pulmonary Patients

Eligibility Criteria

• Age: 8 Years - 99 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with pulmonary disease who do not meet the criteria for existing research protocols.

You may qualify if:

• Patients 8 years old and older with signs or symptoms of pulmonary disease of medical interest to the professional staff of CPB will be eligible for participation in this protocol. Only standard diagnostic procedures and conventional therapy will be performed. Patients will not be subjected to any research procedures. This protocol does not commit the NIH to medical or surgical treatment of protocol participants after discharge. Patients will be discharged to the referring physician.
• Consenting to pregnancy testing in minors of childbearing age:
• We will inform the minor during the assent process that for safety, we need to do a pregnancy test. She will also be told that if it is positive, we will counsel her and help her tell her parents. If the minor does not want to proceed she will be advised not to sign assent and her enrollment on this training protocol will end.

You may not qualify if:

• Patients without symptoms of pulmonary disease will be excluded from this protocol.

Sponsors & Collaborators

• National Heart, Lung, and Blood Institute (NHLBI): lead

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Links

• NIH Clinical Center Detailed Web Page

MeSH Terms

Conditions

Lung Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

• Joel Moss, M.D.

  National Heart, Lung, and Blood Institute (NHLBI)

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: NIH
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 3, 1999
• First Posted: November 4, 1999
• Study Start: February 12, 1997
• Primary Completion: September 25, 2020
• Study Completion: September 25, 2020
• Last Updated: September 28, 2020

Record last verified: 2020-09

Locations

US (1)